The global burden of chronic diseases: overcoming impediments to prevention and control.
By D. Yach, C. Hawkes, C. Gould, K. Hofman. Journal of the American Medical Association (JAMA), 2004
1,513 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Finance, Organizational Behavior and Human Resource Management
View Paper: https://www.semanticscholar.org/paper/3c9336e4072f03ec3abaf6d1abed90735185b212
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Finance
In Organizational Behavior and Human Resource Management
Citations in the corpus
- Internet of Medical Things: A Review of Recent Contributions Dealing With Cyber-Physical Systems in Medicine (2018, positive): “Additionally, the escalation of chronic diseases have pressured healthcare systems around the world due to the lack of resources [2].”
- Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. (2007, background): “The World Health Organization (WHO) estimates that there were approximately 58 million deaths worldwide in 2005, with 35 million attributed to chronic disease.(19,20) In developed countries and lower-middleincome developing nations, CVD and cancer were the leading causes of death.”
- UbeHealth: A Personalized Ubiquitous Cloud and Edge-Enabled Networked Healthcare System for Smart Cities (2018, background): “Chronic diseases are recognized a predominant challenge to global health [108].”
- The anti-inflammatory effect of exercise. (2005, background): “CHRONIC DISEASES ARE THE LARGEST cause of death in the world, led by cardiovascular disease (17 million deaths in 2002) followed by cancer (7 million deaths), chronic lung diseases (4 million), and diabetes mellitus (almost 1 million) (160).”
- Obesity and the metabolic syndrome in developing countries. (2008, background): “A near tripling of CVD mortality in Latin America, the Middle East, and sub-Saharan Africa is expected to occur in next 2 decades (19).”
- Epidemiology and risk profile of heart failure (2010, background): “Although the magnitude of the HF burden in the developing world is not well quantified, enormous growth in the prevalence of HF is expected as developing countries shift from acute illness to chronic disease, the population ages, and the pervasiveness of HF risk factors, such as hypertension, corona”
- Person-Centered Care — Ready for Prime Time (2011, background): “Denoted a silent pandemic, long term diseases are today the leading cause of mortality worldwide and are estimated to be the leading cause of disability by 2020 [1,2].”
- Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. (2006, background): “If green tea does protect humans against CVD or cancer, it is expected that consumption of this beverage would substantially contribute to the prolonging of life expectancy, given that CVD and cancer are the 2 leading causes of death worldwide.(7) To date, 4 studies(8-11) have examined the associati”